News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Versant Venture Capital VI, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/13/2023 |
SC 13D/A
| Versant Venture Capital VI, L.P. reports a 0% stake in OYSTER POINT PHARMA, INC. |
| 01/13/2022 |
SC 13D/A
| Versant Venture Capital VI, L.P. reports a 8.5% stake in OYSTER POINT PHARMA, INC. |
| 10/27/2021 |
SC 13D/A
| Versant Venture Capital VI, L.P. reports a 8.6% stake in OYSTER POINT PHARMA, INC. |
| 06/21/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/24/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/03/2021 |
SC 13D/A
| Versant Venture Capital VI, L.P. reports a 5.1% stake in Aligos Therapeutics, Inc. |
| 04/05/2021 |
SC 13D/A
| Versant Venture Capital VI, L.P. reports a 8.6% stake in OYSTER POINT PHARMA, INC. |
| 03/01/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/03/2020 |
SC 13D/A
| Versant Venture Capital VI, L.P. reports a 12% stake in Black Diamond Therapeutics, Inc. |
| 09/25/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/21/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
|
|